11.82
price down icon1.75%   -0.21
after-market After Hours: 11.56 -0.26 -2.20%
loading
Arcturus Therapeutics Holdings Inc stock is traded at $11.82, with a volume of 322.03K. It is down -1.75% in the last 24 hours and down -7.80% over the past month. Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in one business segment, which includes all activities related to the discovery, development and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU, and LUNAR-COV19.
See More
Previous Close:
$12.03
Open:
$12.47
24h Volume:
322.03K
Relative Volume:
0.78
Market Cap:
$320.56M
Revenue:
$157.75M
Net Income/Loss:
$-29.73M
P/E Ratio:
-10.19
EPS:
-1.16
Net Cash Flow:
$-21.00M
1W Performance:
-2.72%
1M Performance:
-7.80%
6M Performance:
-32.50%
1Y Performance:
-69.23%
1-Day Range:
Value
$11.70
$12.50
1-Week Range:
Value
$11.70
$13.00
52-Week Range:
Value
$8.04
$45.00

Arcturus Therapeutics Holdings Inc Stock (ARCT) Company Profile

Name
Name
Arcturus Therapeutics Holdings Inc
Name
Phone
(858) 900-2660
Name
Address
10628 SCIENCE CENTER DRIVE, SAN DIEGO, CA
Name
Employee
176
Name
Twitter
@ArcturusRx
Name
Next Earnings Date
2024-11-07
Name
Latest SEC Filings
Name
ARCT's Discussions on Twitter

Compare ARCT with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
ARCT
Arcturus Therapeutics Holdings Inc
11.82 329.52M 157.75M -29.73M -21.00M -1.16
Biotechnology icon
ONC
Beigene Ltd Adr
240.41 25.57B 3.81B -644.79M -669.77M -6.24
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
445.10 111.79B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
AKTX
Akari Therapeutics Plc Adr
1.30 39.90M 0 0 0 0.00
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
591.85 65.28B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
VRNA
Verona Pharma Plc Adr
73.93 6.31B 0 -153.72M -103.81M -2.00

Arcturus Therapeutics Holdings Inc Stock (ARCT) Upgrades & Downgrades

Date Action Analyst Rating Change
Jan-28-25 Initiated BTIG Research Buy
Aug-12-24 Initiated Leerink Partners Outperform
Dec-13-23 Initiated Canaccord Genuity Buy
Jul-24-23 Initiated William Blair Outperform
May-11-23 Upgrade H.C. Wainwright Neutral → Buy
Nov-14-22 Resumed Wells Fargo Overweight
Nov-10-22 Downgrade Robert W. Baird Neutral → Underperform
Nov-03-22 Upgrade Citigroup Neutral → Buy
Nov-02-22 Upgrade Barclays Underweight → Equal Weight
Aug-10-22 Downgrade Raymond James Mkt Perform → Underperform
Jul-19-22 Resumed Cantor Fitzgerald Overweight
May-11-22 Upgrade Robert W. Baird Underperform → Neutral
Apr-21-22 Downgrade Citigroup Buy → Neutral
Jan-31-22 Upgrade Raymond James Underperform → Mkt Perform
Aug-12-21 Downgrade Raymond James Mkt Perform → Underperform
Aug-11-21 Downgrade Goldman Neutral → Sell
Aug-10-21 Downgrade Robert W. Baird Neutral → Underperform
Jul-02-21 Initiated Cantor Fitzgerald Overweight
Jun-25-21 Resumed Goldman Neutral
Jun-21-21 Downgrade Barclays Equal Weight → Underweight
Jun-04-21 Resumed Robert W. Baird Neutral
Feb-17-21 Downgrade B. Riley Securities Neutral → Sell
Jan-19-21 Downgrade B. Riley Securities Buy → Neutral
Jan-15-21 Downgrade B. Riley Securities Buy → Neutral
Jan-07-21 Initiated Wells Fargo Overweight
Dec-29-20 Downgrade Barclays Overweight → Equal Weight
Dec-29-20 Downgrade H.C. Wainwright Buy → Neutral
Dec-29-20 Downgrade Raymond James Outperform → Mkt Perform
Dec-29-20 Downgrade Robert W. Baird Outperform → Neutral
Dec-23-20 Downgrade ROTH Capital Buy → Sell
Dec-08-20 Reiterated B. Riley Securities Buy
Dec-07-20 Reiterated B. Riley Securities Buy
Oct-26-20 Initiated Barclays Overweight
Oct-06-20 Initiated Citigroup Buy
Aug-26-20 Initiated Piper Sandler Overweight
Jul-30-20 Resumed ROTH Capital Buy
Jul-16-20 Initiated Raymond James Outperform
Jul-13-20 Initiated B. Riley FBR Buy
Jun-09-20 Downgrade WBB Securities Buy → Hold
Feb-11-20 Initiated Robert W. Baird Outperform
Feb-07-20 Initiated Guggenheim Buy
Feb-06-20 Initiated Guggenheim Buy
Apr-05-19 Initiated H.C. Wainwright Buy
Sep-20-18 Upgrade WBB Securities Buy → Strong Buy
Jan-22-18 Initiated Chardan Capital Markets Buy
View All

Arcturus Therapeutics Holdings Inc Stock (ARCT) Latest News

pulisher
02:28 AM

When the Price of (ARCT) Talks, People Listen - news.stocktradersdaily.com

02:28 AM
pulisher
12:39 PM

Scotiabank Initiates Coverage on Arcturus Therapeutics (ARCT) | - GuruFocus

12:39 PM
pulisher
07:31 AM

Arcturus Therapeutics (ARCT) Receives Positive Outlook with Potential Upside | ARCT Stock News - GuruFocus

07:31 AM
pulisher
07:12 AM

Scotiabank Initiates Arcturus Therapeutics at Outperform - marketscreener.com

07:12 AM
pulisher
May 27, 2025

Man Group plc Sells 4,168 Shares of Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) - Defense World

May 27, 2025
pulisher
May 24, 2025

Arcturus Therapeutics’ SWOT analysis: mRNA innovator’s stock faces pivotal year - Investing.com

May 24, 2025
pulisher
May 24, 2025

Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Given Average Recommendation of “Buy” by Brokerages - Defense World

May 24, 2025
pulisher
May 24, 2025

Wall Street Zen Upgrades Arcturus Therapeutics (NASDAQ:ARCT) to “Hold” - Defense World

May 24, 2025
pulisher
May 22, 2025

Arcturus Therapeutics Holdings (ARCT) Stock Analysis: A 481% Upside Potential Amidst Biotech Innovations - DirectorsTalk Interviews

May 22, 2025
pulisher
May 22, 2025

Northern Trust Corp Has $4.35 Million Stock Position in Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) - Defense World

May 22, 2025
pulisher
May 18, 2025

Trend Tracker for (ARCT) - news.stocktradersdaily.com

May 18, 2025
pulisher
May 17, 2025

Wells Fargo & Company Cuts Arcturus Therapeutics (NASDAQ:ARCT) Price Target to $45.00 - Defense World

May 17, 2025
pulisher
May 16, 2025

Arcturus signals extended cash runway into 2028 with strategic shift toward CF and OTC mRNA therapeutics - MSN

May 16, 2025
pulisher
May 16, 2025

FY2025 EPS Estimates for ARCT Raised by Cantor Fitzgerald - The AM Reporter

May 16, 2025
pulisher
May 16, 2025

Leerink Partnrs Analysts Raise Earnings Estimates for ARCT - Defense World

May 16, 2025
pulisher
May 16, 2025

Price T Rowe Associates Inc. MD Increases Stock Position in Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) - Defense World

May 16, 2025
pulisher
May 16, 2025

William Blair Brokers Boost Earnings Estimates for ARCT - Defense World

May 16, 2025
pulisher
May 15, 2025

Wall Street Analysts Believe Arcturus Therapeutics (ARCT) Could Rally 503.6%: Here's is How to Trade - Yahoo Finance

May 15, 2025
pulisher
May 15, 2025

Canaccord Genuity Group Issues Pessimistic Forecast for Arcturus Therapeutics (NASDAQ:ARCT) Stock Price - Defense World

May 15, 2025
pulisher
May 14, 2025

Arcturus Therapeutics (ARCT): Wells Fargo Maintains Rating, Lowe - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Q1 2025 Earnings Call Transcript - Insider Monkey

May 14, 2025
pulisher
May 14, 2025

Wells Fargo Adjusts Price Target for Arcturus Therapeutics (ARCT - GuruFocus

May 14, 2025
pulisher
May 13, 2025

Arcturus Therapeutics (ARCT) Set for Potential Upside with Citi's Confidence | ARCT Stock News - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Arcturus Therapeutics Holdings Inc earnings missed by $4.11, revenue fell short of estimates - Investing.com Nigeria

May 13, 2025
pulisher
May 13, 2025

Canaccord Genuity Maintains Buy Rating on Arcturus Therapeutics (ARCT) | ARCT Stock News - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Demystifying Arcturus Therapeutics: Insights From 7 Analyst Reviews - Benzinga

May 13, 2025
pulisher
May 13, 2025

Arcturus Therapeutics (ARCT) Price Target Revised by Canaccord | - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Arcturus Therapeutics Holdings Inc (ARCT) Q1 2025 Earnings: EPS - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Arcturus Therapeutics Holdings Inc (ARCT) Q1 2025 Earnings Call Highlights: Strategic Focus and ... - Yahoo Finance

May 13, 2025
pulisher
May 13, 2025

Arcturus Therapeutics Holdings Inc (ARCT) Q1 2025 Earnings Call - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Arcturus Therapeutics Reports Q1 2025 Financial Update - TipRanks

May 13, 2025
pulisher
May 12, 2025

Arcturus Therapeutics (ARCT) Sees Strong Progress with Pipeline Programs - GuruFocus

May 12, 2025
pulisher
May 12, 2025

Earnings call transcript: Arcturus Therapeutics Q1 2025 sees revenue drop, stock rises - Investing.com

May 12, 2025
pulisher
May 12, 2025

Arcturus Therapeutics (ARCT) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance

May 12, 2025
pulisher
May 12, 2025

Arcturus Therapeutics Holdings Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 12, 2025
pulisher
May 12, 2025

Arcturus Therapeutics (ARCT) Surpasses Q1 Revenue Expectations | - GuruFocus

May 12, 2025
pulisher
May 12, 2025

ARCTURUS THERAPEUTICS Earnings Results: $ARCT Reports Quarterly Earnings - Nasdaq

May 12, 2025
pulisher
May 12, 2025

Arcturus Therapeutics stock jumps 7% despite Q1 loss By Investing.com - Investing.com Canada

May 12, 2025
pulisher
May 12, 2025

Arcturus Therapeutics stock jumps 7% despite Q1 loss - Investing.com Australia

May 12, 2025
pulisher
May 12, 2025

Arcturus Therapeutics: Q1 Earnings Snapshot - marketscreener.com

May 12, 2025
pulisher
May 12, 2025

Arcturus Therapeutics Announces First Quarter 2025 Financial Update and Pipeline Progress - Business Wire

May 12, 2025
pulisher
May 10, 2025

Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Shares Sold by Dimensional Fund Advisors LP - Defense World

May 10, 2025
pulisher
May 10, 2025

Arcturus Therapeutics (ARCT) to Release Quarterly Earnings on Monday - Defense World

May 10, 2025
pulisher
May 09, 2025

Earnings To Watch: Arcturus Therapeutics Holdings Inc (ARCT) Reports Q1 2025 Result - Yahoo Finance

May 09, 2025
pulisher
May 08, 2025

MetLife Investment Management LLC Has $283,000 Holdings in Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) - Defense World

May 08, 2025
pulisher
May 06, 2025

Barclays PLC Sells 7,333 Shares of Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) - Defense World

May 06, 2025
pulisher
May 05, 2025

Earnings Preview: Arcturus Therapeutics (ARCT) Q1 Earnings Expected to Decline - Yahoo Finance

May 05, 2025
pulisher
May 04, 2025

Arcturus Therapeutics Holdings Inc.'s (NASDAQ:ARCT) Price Is Right But Growth Is Lacking After Shares Rocket 41% - simplywall.st

May 04, 2025

Arcturus Therapeutics Holdings Inc Stock (ARCT) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$1.05
price down icon 8.70%
$30.28
price down icon 2.39%
$576.24
price down icon 0.61%
$285.56
price down icon 1.56%
$4.35
price up icon 1.64%
$73.93
price down icon 2.22%
Cap:     |  Volume (24h):